Article: Intellectual Property Due Diligence in Psychedelics
Cannabis Law Report
JUNE 19, 2022
The market for psychedelic substances is projected to grow rapidly, potentially outpacing the legal US cannabis market. For example, compounds such as psilocybin, mescaline, ibogaine, and LSD are being evaluated in clinical trials, but the compounds themselves are unpatentable because their existence is well documented in the prior art.
Let's personalize your content